SEARCH
Subscribe
Track all markets on TradingView

Biopharma Stock Pops on License Agreement

Published:

Reading time: 3 min.

Aeterna Zentaris Inc. (TSX:AEZS), a biopharma stock, climbed after announcing a license and assignment agreement with a subsidiary of Strongbridge Biopharma plc

Sean Mason | January 17, 2018 | SmallCapPower

A multi-million-dollar license and assignment agreement gave a big boost to a biopharma stock Wednesday. Here’s some small stocks making big moves on Wednesday, January 17, 2018 (as of 4 pm EST):

Aeterna Zentaris Inc. (TSX:AEZS), a biopharma stock, jumped 16% to $3 on Wednesday after announcing that it has entered into a license and assignment agreement with a wholly-owned subsidiary of Strongbridge Biopharma plc to carry out development, manufacturing, registration and commercialization of Macrilen in the United States and Canada, in consideration for an upfront cash payment of US$24 million plus royalties on net sales.

Win Big With Our Small Cap Picks

 

As well, shares of Advantage Lithium Corp. (TSXV:AAL) added 8% at $1.38 as the lithium junior provided an update on the brine sampling of diamond core hole CAU15 in the south of the previously undrilled NW Sector of the Cauchari JV property in Argentina. The Company said drilling intersected extensive sandy sediments, confirming the NW Sector contains relatively high drainable porosity and permeability south from CAU07 through CAU16 to CAU15, with CAU15 brine averaging 407 mg/l Lithium and 3,196 mg/l Potassium from 102-234.5 metres depth.

Galore Resources Inc. (TSXV:GRI), meanwhile, reported that it has entered into a five-year contract with Urbanizaciones Y Acabados, S.A. De CV to mine gold at Galore’s 100% owned Los Gemelos claim in Mexico. Galore Resources stock moved up 150% to $0.05 following the announcement.

Finally, DIAGNOS Inc. (TSXV:ADK) shares rose 4% to $0.12 after the provider of a technology platform based on Artificial Intelligence for the early detection of critical health issues announced that it will implement a medical blockchain protocol for security control of medical records.

See more Small and Micro Cap Market Movers Daily from Sean Mason. Tomorrow’s big stock market winners could be found here today!

Hi, did you know SmallCapPower accepts blog submissions? You can contact me here

Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.

To read our full disclosure, please click on the button below:

The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.
jsteppke
jsteppke

Related articles

Recent articles

© SmallCapPower 2024